Elevance Health (NYSE:ELV) Issues FY 2026 Earnings Guidance

Elevance Health (NYSE:ELV) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 25.500- for the period, compared to the consensus earnings per share estimate of 26.890. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ELV shares. Sanford C. Bernstein reiterated an “outperform” rating and set a $431.00 price target on shares of Elevance Health in a report on Tuesday, January 6th. Barclays increased their price target on shares of Elevance Health from $385.00 to $404.00 and gave the company an “overweight” rating in a research note on Monday, January 5th. Truist Financial set a $400.00 price target on Elevance Health in a research report on Tuesday, October 14th. JPMorgan Chase & Co. upped their target price on shares of Elevance Health from $384.00 to $394.00 and gave the company an “overweight” rating in a report on Tuesday, October 28th. Finally, Morgan Stanley dropped their target price on Elevance Health from $359.00 to $352.00 and set an “equal weight” rating on the stock in a research report on Wednesday, December 17th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, Elevance Health has an average rating of “Moderate Buy” and a consensus price target of $399.63.

Elevance Health Trading Down 14.4%

NYSE ELV opened at $322.55 on Wednesday. Elevance Health has a 52 week low of $273.71 and a 52 week high of $458.75. The company’s fifty day simple moving average is $350.06 and its 200-day simple moving average is $328.78. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.71. The stock has a market cap of $71.68 billion, a P/E ratio of 13.19, a PEG ratio of 1.94 and a beta of 0.51.

Elevance Health (NYSE:ELV) last issued its earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.07 by $0.26. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. The business had revenue of $49.31 billion for the quarter, compared to analyst estimates of $49.52 billion. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Equities research analysts predict that Elevance Health will post 33.96 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Quarry LP acquired a new position in shares of Elevance Health during the third quarter valued at approximately $62,000. Wiser Advisor Group LLC bought a new position in shares of Elevance Health in the third quarter valued at approximately $75,000. State of Wyoming bought a new stake in Elevance Health during the second quarter valued at about $127,000. Prosperity Consulting Group LLC grew its holdings in Elevance Health by 24.8% in the 3rd quarter. Prosperity Consulting Group LLC now owns 710 shares of the company’s stock valued at $229,000 after buying an additional 141 shares during the last quarter. Finally, Transamerica Financial Advisors LLC grew its stake in shares of Elevance Health by 43.9% in the second quarter. Transamerica Financial Advisors LLC now owns 616 shares of the company’s stock worth $239,000 after acquiring an additional 188 shares during the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.